---

Carsten Brockmeyer

Chief Executive Officer, Formycon AG

“For me, my greatest achievement is the development of Binocrit (epoetin alfa), the world’s first complex biosimilar anemia drug,” says Carsten. “I designed the strategy and led the cross-functional team, which succeeded by applying quality-by-design principles for biosimilars from R&D to commercialization. It resulted in the highly successful launch of Binocrit and I think it’s a major game changer in global access to quality medicines.”

www.formycon.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015